2022 Archives - Biocryst

Population Pharmacokinetic Modeling and Simulations of Berotralstat for Prophylactic Treatment of Attacks of Hereditary Angioedema

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
A Case of Normal C1 Esterase Inhibitor Hereditary Angioedema Successfully Treated with Berotralstat

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Attenuated Androgen Discontinuation in Patients with Hereditary Angioedema: a Commented Case Series

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Long-Term Prophylaxis in Hereditary Angioedema Management: Current Practices in France and Unmet Needs

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Shared Decision-Making in the Management of Hereditary Angioedema: An Analysis of Patient and Physician Perspectives

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Global Perceptions of the Current and Future Impacts of COVID-19 on Hereditary Angioedema Management

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Expert Consensus on Prophylactic Treatment of Hereditary Angioedema

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Microinjection via the suprachoroidal space: a review of a novel mode of administration

View Article

biocryst

January 27, 2025

Diabetic Macular Edema (DME)
Molecules related to diabetic retinopathy in the vitreous and involved pathways

View Article

biocryst

January 27, 2025

Diabetic Macular Edema (DME)
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications

View Article

biocryst

January 27, 2025

Diabetic Macular Edema (DME)